Decoy Therapeutics Inc. Asset Acquisition Consideration Transferred
Financial Statements › Balance Sheet › Assets › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Asset Acquisition, Consideration Transferred
us-gaap:AssetAcquisitionConsiderationTransferred · last filed 2026-03-31
- Decoy Therapeutics Inc. asset acquisition consideration transferred for fiscal 2025 was $6.59M.
| Period end | Asset Acquisition Consideration Transferred | Asset Acquisition Consideration Transferred 12 month |
|---|---|---|
| 2025-12-31 | $6.59M 10-K · filed 2026-03-31 | |
| 2025-11-12 | $4.30M 10-K · filed 2026-03-31 |